A Danish evaluation carried out in 2021 found apolipoprotein C-I, apolipoprotein A-II, augurin, receptor-type tyrosine protein phosphatase-γ and trypsin-1 to be upregulated in the CSF of MS patients, regardless of the disease subtype as compared to healthy controls [149]. This evidence concerns the gene PTPRG and myeloid sarcoma.